{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:08:48Z","timestamp":1791562128725,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejcancer.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.ejca.2014.05.019","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T21:10:47Z","timestamp":1403644247000},"page":"2309-2318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":185,"title":["Changing incidence and improved survival of gliomas"],"prefix":"10.1016","volume":"50","author":[{"given":"Vincent K.Y.","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap C.","family":"Reijneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roelien H.","family":"Enting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri P.","family":"Bienfait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Robe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitta G.","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2014.05.019_b0005","unstructured":"Central Brain Tumor Registry of the United States. Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004\u20132006; 2010."},{"issue":"9","key":"10.1016\/j.ejca.2014.05.019_b0010","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/jnci\/djr077","article-title":"Annual report to the nation on the status of cancer, 1975\u20132007, featuring tumors of the brain and other nervous system","volume":"103","author":"Kohler","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.ejca.2014.05.019_b0015","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.ejca.2011.12.013","article-title":"Epidemiology of glial and non-glial brain tumours in Europe","volume":"48","author":"Crocetti","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2014.05.019_b0020","series-title":"WHO classification of tumours of the central nervous system","year":"2007"},{"issue":"10","key":"10.1016\/j.ejca.2014.05.019_b0025","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejca.2014.05.019_b0030","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"issue":"Suppl. 2","key":"10.1016\/j.ejca.2014.05.019_b0035","first-page":"ii31","article-title":"The dilemma of low grade glioma","volume":"75","author":"Whittle","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.ejca.2014.05.019_b0040","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ncl.2010.03.022","article-title":"Management of diffuse low-grade cerebral gliomas","volume":"28","author":"Prabhu","year":"2010","journal-title":"Neurol Clin"},{"issue":"8","key":"10.1016\/j.ejca.2014.05.019_b0045","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1200\/JCO.2005.05.2399","article-title":"Diffusely infiltrative low-grade gliomas in adults","volume":"24","author":"Lang","year":"2006","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1016\/j.ejca.2014.05.019_b0050","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1212\/01.wnl.0000277271.47601.a1","article-title":"Outcome in adult low-grade glioma: the impact of prognostic factors and treatment","volume":"69","author":"Schiff","year":"2007","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ejca.2014.05.019_b0055","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ana.410310413","article-title":"Suspected low-grade glioma: is deferring treatment safe?","volume":"31","author":"Recht","year":"1992","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.ejca.2014.05.019_b0060","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1212\/WNL.56.5.618","article-title":"Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas","volume":"56","author":"Reijneveld","year":"2001","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ejca.2014.05.019_b0065","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/jnnp.64.5.581","article-title":"Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery","volume":"64","author":"van Veelen","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.ejca.2014.05.019_b0070","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12254-012-0014-3","article-title":"Current treatment of low grade gliomas","volume":"5","author":"van den Bent","year":"2012","journal-title":"Memo"},{"issue":"9","key":"10.1016\/j.ejca.2014.05.019_b0075","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1468-1331.2010.03151.x","article-title":"Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force","volume":"17","author":"Soffietti","year":"2010","journal-title":"Eur J Neurol"},{"issue":"18","key":"10.1016\/j.ejca.2014.05.019_b0080","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1001\/jama.2012.12807","article-title":"Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas","volume":"308","author":"Jakola","year":"2012","journal-title":"JAMA"},{"issue":"1 Suppl.","key":"10.1016\/j.ejca.2014.05.019_b0085","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/1097-0142(19950101)75:1+<330::AID-CNCR2820751315>3.0.CO;2-5","article-title":"Brain, other central nervous system, and eye cancer","volume":"75","author":"Polednak","year":"1995","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2014.05.019_b0090","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/1097-0142(19951101)76:9<1634::AID-CNCR2820760921>3.0.CO;2-0","article-title":"The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly","volume":"76","author":"Werner","year":"1995","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2014.05.019_b0095","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3171\/jns.1995.83.6.0999","article-title":"The incidence of primary central nervous system neoplasms before and after computerized tomography availability","volume":"83","author":"Helseth","year":"1995","journal-title":"J Neurosurg"},{"issue":"339","key":"10.1016\/j.ejca.2014.05.019_b0100","doi-asserted-by":"crossref","first-page":"b3016","DOI":"10.1136\/bmj.b3016","article-title":"Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis","volume":"17","author":"Morris","year":"2009","journal-title":"BMJ"},{"issue":"16","key":"10.1016\/j.ejca.2014.05.019_b0105","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/jnci\/91.16.1382","article-title":"Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality","volume":"91","author":"Legler","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ejca.2014.05.019_b0110","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/02841860500543190","article-title":"Stable incidence of childhood and adult glioma in The Netherlands, 1989\u20132003","volume":"45","author":"Houben","year":"2006","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2014.05.019_b0115","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00001622-200105000-00005","article-title":"Brain and other central nervous system tumors: rates, trends, and epidemiology","volume":"13","author":"Gurney","year":"2001","journal-title":"Curr Opin Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2014.05.019_b0120","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/ije\/24.6.1078","article-title":"Trends in incidence of primary malignant brain tumors in USA, 1981\u20131990","volume":"24","author":"Ahsan","year":"1995","journal-title":"Int J Epidemiol"},{"issue":"3","key":"10.1016\/j.ejca.2014.05.019_b0125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000075952","article-title":"Trends in incidence of brain and central nervous system tumors in Norway, 1970\u20131999","volume":"23","author":"Johannesen","year":"2004","journal-title":"Neuroepidemiology"},{"issue":"3","key":"10.1016\/j.ejca.2014.05.019_b0130","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ijc.11578","article-title":"Incidence trends of adult primary intracerebral tumors in four Nordic countries","volume":"108","author":"Lonn","year":"2004","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2014.05.019_b0135","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1215\/S1522851705000323","article-title":"Temporal trends in incidence of primary brain tumors in the United States, 1985\u20131999","volume":"8","author":"Hoffman","year":"2006","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2014.05.019_b0140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/NEN.0b013e31820681aa","article-title":"Grading of gliomas: the road from eminence to evidence","volume":"70","author":"Kros","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"10.1016\/j.ejca.2014.05.019_b0145","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ije\/22.3.369","article-title":"Completeness of cancer registration in Limburg, The Netherlands","volume":"22","author":"Schouten","year":"1993","journal-title":"Int J Epidemiol"},{"issue":"2","key":"10.1016\/j.ejca.2014.05.019_b0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/jech.44.2.121","article-title":"General practitioners and completeness of cancer registry","volume":"44","author":"Berkel","year":"1990","journal-title":"J Epidemiol Community Health"},{"issue":"5","key":"10.1016\/j.ejca.2014.05.019_b0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000026176","article-title":"A uniform histological cluster scheme for ICD-O-coded primary central nervous system tumors","volume":"17","author":"van der Sanden","year":"1998","journal-title":"Neuroepidemiology"},{"issue":"340","key":"10.1016\/j.ejca.2014.05.019_b0160","doi-asserted-by":"crossref","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes","volume":"12","author":"Levesque","year":"2010","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ejca.2014.05.019_b0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11060-009-9938-9","article-title":"The Austrian Brain Tumour Registry: a cooperative way to establish a population-based brain tumour registry","volume":"95","author":"Wohrer","year":"2009","journal-title":"J Neurooncol"},{"issue":"6","key":"10.1016\/j.ejca.2014.05.019_b0170","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/jnen\/64.6.479","article-title":"Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas","volume":"64","author":"Ohgaki","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"10.1016\/j.ejca.2014.05.019_b0175","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ejca.2014.05.019_b0180","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1470-2045(12)70265-6","article-title":"Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial","volume":"13","author":"Malmstrom","year":"2012","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2014.05.019_b0185","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1470-2045(12)70164-X","article-title":"Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial","volume":"13","author":"Wick","year":"2012","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2014.05.019_b0190","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1200\/JCO.2012.43.2229","article-title":"Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951","volume":"31","author":"van den Bent","year":"2013","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.ejca.2014.05.019_b0195","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1200\/JCO.2006.08.0705","article-title":"Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma","volume":"25","author":"Pelloski","year":"2007","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2014.05.019_b0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ccr.2006.02.019","article-title":"Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis","volume":"9","author":"Phillips","year":"2006","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.ejca.2014.05.019_b0205","first-page":"1602","article-title":"Gene expression-based classification of malignant gliomas correlates better with survival than histological classification","volume":"63","author":"Nutt","year":"2003","journal-title":"Cancer Res"},{"issue":"21","key":"10.1016\/j.ejca.2014.05.019_b0210","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1101\/gad.1596707","article-title":"Malignant astrocytic glioma: genetics, biology, and paths to treatment","volume":"21","author":"Furnari","year":"2007","journal-title":"Genes Dev"},{"issue":"4","key":"10.1016\/j.ejca.2014.05.019_b0215","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-12-3002","article-title":"The definition of primary and secondary glioblastoma","volume":"19","author":"Ohgaki","year":"2013","journal-title":"Clin Cancer Res"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804914007187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804914007187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T04:28:05Z","timestamp":1538540885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804914007187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":43,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0959804914007187"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2014.05.019","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changing incidence and improved survival of gliomas","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2014.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}